MPRIP-ALK, a Novel ALK Rearrangement That Responds to ALK Inhibition in NSCLC.

MLA

Lu, Feng, et al. “MPRIP-ALK, a Novel ALK Rearrangement That Responds to ALK Inhibition in NSCLC.” Journal of Thoracic Oncology, vol. 14, no. 7, July 2019, pp. e148–51. EBSCOhost, https://doi.org/10.1016/j.jtho.2019.02.030.

APA

Lu, F., Zhang, L., Fang, W., Gan, J., & Hong, S. (2019). MPRIP-ALK, a Novel ALK Rearrangement That Responds to ALK Inhibition in NSCLC. Journal of Thoracic Oncology, 14(7), e148–e151. https://doi.org/10.1016/j.jtho.2019.02.030

Chicago

Lu, Feng, Li Zhang, Wenfeng Fang, Jiadi Gan, and Shaodong Hong. 2019. “MPRIP-ALK, a Novel ALK Rearrangement That Responds to ALK Inhibition in NSCLC.” Journal of Thoracic Oncology 14 (7): e148–51. doi:10.1016/j.jtho.2019.02.030.